Claims
- 1. An oral pharmaceutical dosage form not susceptible to abuse by mucosal membrane administration providing a plasma concentration that does not exceed the therapeutic concentration.
- 2. An oral pharmaceutical dosage form not susceptible to abuse by respiratory mucosal membrane administration providing a plasma concentration that does not exceed the therapeutic concentration.
- 3. An oral pharmaceutical dosage form not susceptible to abuse by mastication providing a plasma concentration that does not exceed the therapeutic concentration.
- 4. An oral pharmaceutical dosage form not susceptible to abuse by injection of an illicit extract of said oral dosage form providing a plasma concentration that does not exceed the therapeutic concentration.
- 5. An oral pharmaceutical dosage form not susceptible to abuse by mucosal membrane administration providing a plasma concentration that does not exceed the therapeutic concentration comprising a complex of a controlled substance and an ion exchange resin.
- 6. An oral pharmaceutical dosage form not susceptible to abuse by respiratory mucosal membrane administration providing a plasma concentration that does not exceed the therapeutic concentration comprising a complex of a controlled substance and an ion exchange resin.
- 7. An oral pharmaceutical dosage form not susceptible to abuse by mastication providing a plasma concentration that does not exceed the therapeutic concentration comprising a complex of a controlled substance and an ion exchange resin.
- 8. An oral pharmaceutical dosage form not susceptible to abuse by injection of an illicit extract of said oral dosage form providing a plasma concentration that does not exceed the therapeutic concentration comprising a complex of a controlled substance and an ion exchange resin.
- 9. An oral pharmaceutical dosage form according to claim 5, wherein said controlled substance is selected from the group consisting of Schedule, II, III, IV or V controlled substances.
- 10. An oral pharmaceutical dosage form according to claim 6, wherein said controlled substance is selected from the group consisting of Schedule, II, III, IV or V controlled substances.
Parent Case Info
[0001] This application claims benefit to provisional application No. 60/322,768, filed Sep. 17, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60322768 |
Sep 2001 |
US |